128 related articles for article (PubMed ID: 33847423)
1. Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation.
Piperoglou C; Larid G; Vallentin B; Balligand L; Crinier A; Banzet N; Farnarier C; Gomez-Massa E; Adalia AC; ; Michel G; Galambrun C; Barlogis V; Vivier E; Vély F
J Leukoc Biol; 2022 Jan; 111(1):161-172. PubMed ID: 33847423
[TBL] [Abstract][Full Text] [Related]
2. Presence of innate lymphoid cells in allogeneic hematopoietic grafts correlates with reduced graft-versus-host disease.
Kroeze A; van Hoeven V; Verheij MW; Turksma AW; Weterings N; van Gassen S; Zeerleder SS; Blom B; Voermans C; Hazenberg MD
Cytotherapy; 2022 Mar; 24(3):302-310. PubMed ID: 35058143
[TBL] [Abstract][Full Text] [Related]
3. Innate lymphoid cells in graft-versus-host disease.
Konya V; Mjösberg J
Am J Transplant; 2015 Nov; 15(11):2795-801. PubMed ID: 26228632
[TBL] [Abstract][Full Text] [Related]
4. Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease.
Quatrini L; Tumino N; Moretta F; Besi F; Vacca P; Moretta L
Front Immunol; 2020; 11():582098. PubMed ID: 33101308
[TBL] [Abstract][Full Text] [Related]
5. Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.
Munneke JM; Björklund AT; Mjösberg JM; Garming-Legert K; Bernink JH; Blom B; Huisman C; van Oers MH; Spits H; Malmberg KJ; Hazenberg MD
Blood; 2014 Jul; 124(5):812-21. PubMed ID: 24855210
[TBL] [Abstract][Full Text] [Related]
6. Source of hematopoietic progenitor cells determines their capacity to generate innate lymphoid cells ex vivo.
Omar SZ; van Hoeven V; Haverkate NJE; Van der Meer JMR; Voermans C; Blom B; Hazenberg MD
Cytotherapy; 2024 Apr; 26(4):334-339. PubMed ID: 38363249
[TBL] [Abstract][Full Text] [Related]
7. Group 3 innate lymphoid cells in tissue damage and graft-versus-host disease pathogenesis.
Karrich JJ; Cupedo T
Curr Opin Hematol; 2016 Jul; 23(4):410-5. PubMed ID: 27135976
[TBL] [Abstract][Full Text] [Related]
8. Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease.
Hazenberg MD; Haverkate NJE; van Lier YF; Spits H; Krabbendam L; Bemelman WA; Buskens CJ; Blom B; Shikhagaie MM
Blood Adv; 2019 Nov; 3(22):3650-3660. PubMed ID: 31751473
[TBL] [Abstract][Full Text] [Related]
9. Innate protection from graft-versus-host disease.
Cupedo T
Blood; 2014 Jul; 124(5):673-5. PubMed ID: 25082864
[TBL] [Abstract][Full Text] [Related]
10. Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.
Zaghi E; Calvi M; Di Vito C; Mavilio D
Front Immunol; 2019; 10():2794. PubMed ID: 31849972
[TBL] [Abstract][Full Text] [Related]
11. The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF.
Moretta F; Petronelli F; Lucarelli B; Pitisci A; Bertaina A; Locatelli F; Mingari MC; Moretta L; Montaldo E
Eur J Immunol; 2016 May; 46(5):1271-8. PubMed ID: 26840535
[TBL] [Abstract][Full Text] [Related]
12. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
Front Immunol; 2019; 10():1997. PubMed ID: 31507601
[TBL] [Abstract][Full Text] [Related]
13. NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation.
Vacca P; Montaldo E; Croxatto D; Moretta F; Bertaina A; Vitale C; Locatelli F; Mingari MC; Moretta L
Front Immunol; 2016; 7():188. PubMed ID: 27242795
[TBL] [Abstract][Full Text] [Related]
14. Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation.
Davies JK; Brennan LL; Wingard JR; Cogle CR; Kapoor N; Shah AJ; Dey BR; Spitzer TR; de Lima M; Cooper LJ; Thall PF; Champlin RE; Nadler LM; Guinan EC
Clin Cancer Res; 2018 Sep; 24(17):4098-4109. PubMed ID: 29769208
[No Abstract] [Full Text] [Related]
15. Glucocorticoids inhibit human hematopoietic stem cell differentiation toward a common ILC precursor.
Quatrini L; Tumino N; Besi F; Ciancaglini C; Galaverna F; Grasso AG; Merli P; Locatelli F; Vacca P; Moretta L
J Allergy Clin Immunol; 2022 May; 149(5):1772-1785. PubMed ID: 34688777
[TBL] [Abstract][Full Text] [Related]
16. Quantity and Quality Reconstitution of NKG2A
Hu LJ; Zhao XY; Yu XX; Lv M; Han TT; Han W; Huang XJ
Biol Blood Marrow Transplant; 2019 Jan; 25(1):1-11. PubMed ID: 30142416
[TBL] [Abstract][Full Text] [Related]
17. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
[TBL] [Abstract][Full Text] [Related]
18. ILCs in hematologic malignancies: Tumor cell killers and tissue healers.
Blom B; van Hoeven V; Hazenberg MD
Semin Immunol; 2019 Feb; 41():101279. PubMed ID: 31200953
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution.
Makanga DR; Guillaume T; Willem C; Legrand N; Gagne K; Cesbron A; Gendzekhadze K; Peterlin P; Garnier A; Le Bourgeois A; Béné MC; Chevallier P; Retière C
J Immunol; 2020 Sep; 205(5):1441-1448. PubMed ID: 32747504
[TBL] [Abstract][Full Text] [Related]
20. An Essential Role of Innate Lymphoid Cells in the Pathophysiology of Graft-vs.-Host Disease.
Shao L; Pan S; Zhang QP; Jamal M; Chen LH; Yin Q; Wu YJ; Xiong J; Xiao RJ; Kwong YL; Zhou FL; Lie AKW
Front Immunol; 2019; 10():1233. PubMed ID: 31244831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]